Combination of escitalopram and a 5-HT1A receptor antagonist selectively decreases the extracellular levels of dopamine in the nucleus accumbens relative to striatum through 5-HT2C receptor stimulation; suggestive of antipsychotic potential
Keywords: همزمان escitalopram; Escitalopram; WAY-100635; SB242084; Conditioned avoidance response behaviour; Microdialysis; Dopamine; Nucleus accumbens; Striatum; 5-HT2C receptor antipsychotic;